https://www.pharmalive.com/wp-content/uploads/2022/05/New-class-of-cancer-drugs-down-not-out-after-Roche-trial-setback-–-analysts-Reuters-5-11-22.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-06-24 07:44:482022-06-24 09:17:19Roche skeptical about investing more in 'guided-missile' ADC cancer drugs
